| Management number | 251642667 | Release Date | 2026/09/26 | List Price | US$81.24 | Model Number | 251642667 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
The first FDA conditionally approved, once-weekly drug for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy; or HCM. A silent killer of cats that affects one of every seven cats. The solution of Felycin-CA1 is the only disease-modifying drug for cats with HCM.
| Animal type | Cat |
|---|---|
| Prescription medicine type | Prescription Medicine |
| Animal health concern | Heart Care |
| Pharmacy product status | Active |
| Animal lifestage | All Lifestages |
| Medicine form | Oral |
| Enteral medication form | Tablets |
| Treatment effective time | 1 wk |
| Pharmacy product category | GENERIC_RX |
| Count per pack | 12 |
| Fda approved for animals | Y |
| Is intended for human consumption | N |
| Product net content parent | 12 Each |
| Product net content uom | Each |
| Size | 2.4mg |
| Dea class | None/NC (Not Controlled) |
| Label image | No Label |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form